Curaleaf Holdings, Inc.
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$2.76B
Cash Runway
1.0 mo
Lead Asset
—
Next Catalyst
—
Go deeper on Curaleaf Holdings, Inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on CURLF — live, with citations.
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
1.0 months
D/E 2.65
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Key Financialsas of December 31, 2025
Cash
$101.6M
Quarterly Burn
$605.6M
Revenue
$1.27B
Free Cash Flow
$88.6M
Total Liabilities
$2.01B
Shareholders Equity
$756.4M
Current Ratio
1.52
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
5
Total value held
$233K
| Holder | Shares | Value |
|---|---|---|
| albert d mason inc | 75,079 | $161K |
| nano cap new millennium growth fund l p | 32,500 | $70K |
| mark sheptoff financial planning, llc | 800 | $3K |
| ancora advisors llc | 100 | $214 |
| nbc securities, inc. | 22 | $47 |
Frequently asked questions
Who is the CEO of Curaleaf Holdings, Inc.?
Mr. Boris Alexis Jordan is the chief executive officer of Curaleaf Holdings, Inc. (CURLF).
Where is Curaleaf Holdings, Inc. headquartered?
Curaleaf Holdings, Inc. (CURLF) is headquartered in Stamford, CT, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Curaleaf Holdings, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.